The company was founded in 2004 in Pirmasens. It develops innovative products for the prevention of stroke. apoplex medical technologies draws from an extensive academic and clinical network which complements the own core competencies in mathematics, physics and medicine.
Our mission is in the first place to educate about the probably most dangerous single risk factor for stroke, the atrial fibrillation, and in the second place to fight it with the Stroke Risk Analysis SRA ®.
Our visionis that throughout the world no stroke will occur because of undetected atrial fibrillation, starting with Germany and Europe.